Podcasts about ozempic

Why do some people look amazing after procedures while others look strange, swollen and are frankly regretful? In this episode, I'm sitting down again with Dr. Rady Rahban, a Beverly Hills board-certified plastic and reconstructive surgeon, to get brutally honest about what women need to know before plastic surgery. We talk about the procedures that can look beautiful when done well, the ones that are overdone or misunderstood, and the red flags that should make you walk away from a surgeon. My goal is to help you feel informed, empowered, and clear-eyed so you can make decisions from confidence instead of fear, pressure, or hype. What you'll learn: (07:13) Modern plastic surgery techniques and anesthesia make procedures safer than ever, but marketing hype can still cloud patient judgment. (08:49) Brazilian Butt Lifts involve highly aggressive liposuction and carry a deadly risk of fat embolisms if injected incorrectly into the muscle. (14:24) A revolutionary donor product called Aliclay allows lean, fit individuals to add cosmetic volume without needing their own harvestable fat. (19:52) The phenomenon known as "Ozempic face" is primarily the natural result of rapid weight loss rather than a specific drug side effect. (24:55) A natural-looking facelift relies entirely on a skilled surgeon knowing exactly how much to adjust the tissue dial without over-pulling. (32:13) Extensive body contouring after massive weight loss requires a highly detailed prioritization plan and realistic economic budgeting. (35:23) Many body contouring surgeons utilize unvetted assistant teams to perform extensive suturing while the primary surgeon exits the room. (38:01) Finding a reputable surgeon requires identifying specific red flags, such as high-pressure sales tactics or a disorganized office environment. Love the podcast? Here's what to do: Subscribe to the podcast. Leave a review. Text a screenshot to me at 813-565-2627 and wait for a personal reply because your voice is so important to me. Full show notes (including all links mentioned): https://jjvirgin.com/drrady Episode Sponsor: Try Qualia risk-free for up to 100 days and use code VIRGINWELLNESS for 15% off If your routine or eating habits have changed recently head to BodyBio.com/JJVIRGIN to start supporting your gut. Mitopure supports the cellular energy that allows your muscles to actually respond and adapt. Mitopure gummies make it simple. Visit https://timeline.com/jjvirgin for 20% off your order. Learn more about your ad choices. Visit megaphone.fm/adchoices

Something strange is happening. People are drinking less alcohol. Not because they joined a recovery program. Not because they found religion. Not because they suddenly became health gurus. Instead, they're taking Ozempic, talking to AI companions, binge-watching Netflix, ordering DoorDash, and staying home. In this solo episode, Shane dives into one of the biggest cultural shifts happening right now. What if alcohol isn't disappearing because society got healthier? What if it's simply being replaced? We explore how GLP-1 drugs like Ozempic are reducing alcohol cravings, why AI companions are becoming a substitute for human connection, and how technology is quietly replacing the role bars and happy hours once played in our lives. This isn't just a conversation about sobriety. It's a conversation about culture, connection, loneliness, comfort, and where we're headed next. The future may be sober. But it might not be for the reasons we think. In this episode: • How Ozempic could disrupt the alcohol industry• Why AI companions are exploding in popularity• The decline of happy hour culture• What technology is replacing in our lives• The hidden connection between alcohol, dopamine, and modern comfort If you've ever wondered where drinking culture is headed, this episode is for you. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Rebecca Morrison is healthy by many measures. But like millions of people today, she finds herself wondering whether or not she should be taking a GLP-1 drug. What's the right thing to do? This episode explores how this new class of weight loss drugs is reshaping our healthcare choices, and the landscape in which we make them.You can read more about Rebecca Morrison's story in her novel, The Blue Dress, released March 2026. This episode features:Rebecca K. Morrison: Writer.Mara Gordon, MD: Primary Care Physician at Cooper University Hospital and Assistant Professor of Family Medicine at Cooper Medical School of Rowan University.Alexandra Brewis, PhD: Regents Professor and President's Professor at the School of Human Evolution and Social Change at Arizona State University.Jeffrey Kahn, PhD, MPH: Andreas C. Dracopoulos Director of the Johns Hopkins Berman Institute of Bioethics.“playing god?” is a podcast by the iDeas Lab at the Johns Hopkins Berman Institute of Bioethics. To read a transcript of this episode, visit the iDeas Lab website at https://bioethics.jhu.edu/pgs2e5.The Johns Hopkins University Sesquicentennial is proud to support this podcast. JHU celebrates 150 years of pioneering education and research—advancing knowledge to meet the challenges of every generation. Learn more at 150.jhu.edu.

If you've been anywhere near the internet in the last couple of years, you've heard about Ozempic and GLP-1 drugs. You've seen the before-and-afters. Maybe a friend asked if you should try it too. And if you're like most of the women Dr. Shivani works with, you may feel confused. The results look real, but something feels off. Are we treating a symptom? Are we missing something deeper?In this episode, Dr. Shivani Gupta tells the story of Veronica, a client who came to her terrified after a bad experience with GLP-1 medication, but still wanting to lose weight, reduce inflammation, and feel like herself again.Through Veronica's story, Dr. Shivani breaks down what GLP-1 actually is, why so many people have a weakened natural GLP-1 response, and how Ayurveda has been supporting this same pathway through agni, bitter foods, gut health, and daily rhythm.You'll learn:What GLP-1 actually is and why your body already makes itWhy GLP-1 drugs work on inflammation, not just appetiteWhy processed food, stress, sleep, and gut imbalance can blunt your natural GLP-1 responseThe Ayurvedic concept of agni and how it connects to GLP-1 biologyNatural ways to support your body's GLP-1 pathway using food, herbs, and rhythmWhat GLP-1 drugs may be helpful for, and what Dr. Shivani wants women to understand firstHow Veronica rebuilt her foundation naturally

Niamh emails in raging about the amount of people taking “fat jabs” like Ozempic and Mounjaro, calling them the “lazy way out” and saying weight loss should be done the old-fashioned way — diet and exercise.Adrian argues it's nobody's business how someone loses weight, once they're healthier. Jeremy isn't having it, saying people don't deserve praise if “the jab did the work”.Stay listening for the awkward moment when Jeremy is called out by a colleague.

People using GLP-1 drugs like Ozempic lose about 7% of their facial fat for every 22 pounds of body weight lost, resulting in a hollow, prematurely aged look Rapid weight loss may drain key nutrients and fatty acids that your body needs to produce collagen and maintain firm, healthy skin "Ozempic face" may indicate an energy imbalance — your cells lose the fuel and structural support they need to keep skin elastic and vibrant Avoiding GLP-1 drugs, eliminating seed oils, and restoring gut health may support metabolic recovery, which research suggests could help restore facial tone and fullness over time Natural tools like polyphenol-rich foods and the right carbohydrates may support weight management without draining your body's nutrient reserves

In this episode, I sit down with Houston-based plastic surgeon Dr. Vinaya Rednam, who specializes in surgery for patients who've lost massive amounts of weight. We get into everything from GLP-1 medications and how they affect tissue quality, to the most common body contouring surgeries after major weight loss, and what you need to know before going under the knife.  Topics Discussed: → Who is a good candidate for massive weight loss body contouring? → How do GLP-1 medications affect loose skin and surgical results? → Can you prevent loose skin while losing weight? → What should you know before getting a lower body lift? → Are non-surgical skin tightening treatments worth it? → What should you expect from arm lifts, breast lifts, and thigh lifts? → When is the right time to consider surgery after major weight loss?

➢ DM “FAT LOSS” To @ ColossusFitWelcome to Motivation Monday, where every Monday we answer all of your questions and have some real talks about life & fitness & get you fired up for the week! In this episode we talk about......Josh quote: “Rock bottom is a trampoline.”Kyle quote: “Hindsight is 2020.”After something happens, it's easy to look back and think the right answer was obvious.What has us excited or intrigued:Client shoutout: Anthony FeraWeekly questions:Are people actually getting healthier, or are we just getting better at buying health products?If your watch says you slept poorly but you feel fine, should you trust the data or your body?How do you stay fit when groceries, life, kids, mortgages, and stress all feel more expensive and demanding than ever?Thanks for listening! We genuinely appreciate every single one of you listening.Email me/ submit a mailbox Monday question contact@colossusfitness.com➢Follow us on instagram @colossusfit➢Apply to get your Polished Physique: https://colossusfitness.com/

I'm exposing the truth about how high-protein foods can mimic the appetite-suppressing effects of weight loss drugs but with benefits instead of side effects. When you use Ozempic or similar medications, up to 40% of your weight loss can come from muscle, devastating your metabolism and setting you up for rebound fat gain. Protein, however, works naturally with your body's hunger hormones—slashing ghrelin for 3+ hours, maintaining healthy leptin levels, and boosting PYY—all while providing essential amino acids for mood-regulating neurotransmitters. I'm sharing my complete Ozempic-mimicking protein protocol, including the magic combination with fiber that naturally stimulates GLP-1 production (the same hormone triggered by those expensive medications). Plus, protein's thermogenic effect means you'll burn more calories digesting it, and when paired with resistance training, you'll maintain or even build metabolism-boosting muscle rather than losing it. What you'll learn: How protein naturally controls hunger through three key hormonal pathways Why Ozempic and similar drugs can cause dangerous muscle loss (up to 40%) The specific protein amounts needed at morning and evening "bumper meals" to control cravings Which protein sources provide the best metabolic benefits How to pair protein with fiber for maximum GLP-1 production The importance of resistance training in a protein-focused weight loss approach Why protein shakes outperformed Ozempic in a recent study for fat loss while preserving muscle Love the podcast? Here's what to do: Subscribe to the podcast. Leave a review. Text a screenshot to me at 813-565-2627 and wait for a personal reply because your voice is so important to me. Learn more about your ad choices. Visit megaphone.fm/adchoices

‣ Apply to Join Dieting From The Inside Out Here: https://inquire.hamiltontrained.com?utm_source=podcast‣ Grab the Food Noise Solution Guide Here: https://inquire.hamiltontrained.com/food-noise?utm_source=podcast

Discover why hormones are off and what's really driving the imbalance. In this episode, we break down five root causes — from gut dysfunction and disrupted sleep to chronic stress, appetite dysregulation, and omega-3 deficiency — and walk through what you can actually do to fix it. FEATURED PRODUCT Berberine is a powerful botanical compound that acts as a natural GLP-1 supporter — the same metabolic pathway targeted by medications like Ozempic — helping regulate blood sugar, reduce insulin resistance, and restore appetite signaling from the gut. Since metabolic hormones like insulin and leptin are the first to derail your entire hormone cascade, Berberine directly addresses one of the deepest root causes discussed in this episode. It also supports gut microbiome diversity, making it a foundational tool for anyone working to reclaim hormonal balance naturally.

Worried about gaining weight back after Ozempic, Wegovy, Mounjaro, or Zepbound?You're not alone. One of the biggest concerns people have during their GLP-1 journey is what happens after the weight loss phase—and how to actually maintain their results long-term.In this episode, Registered Dietitian and GLP-1 expert Gianna breaks down what sustainable weight maintenance really looks like, why maintaining weight loss is different from losing weight, and the habits that support long-term success.Because keeping weight off isn't about being perfect. It's about building routines that you can realistically maintain for years to come.We're covering:Why weight maintenance is different than weight lossCommon reasons people regain weight after losing itThe role of appetite, food noise, and long-term behavior changeWhy protein and strength training matter for maintenanceHow muscle supports long-term health and weight managementThe mindset shifts that make maintenance easierWhy all-or-nothing thinking keeps people stuckWhat successful long-term maintenance actually looks likeWhether you're currently taking Ozempic, Wegovy, Mounjaro, or Zepbound—or simply thinking ahead to the future—this episode will help you focus on the habits that support lasting results.

En este episodio de Creadores Podcast, Marcelo Zegarra conversa con el Dr. Joaqui, anestesiólogo, especialista en dolor y experto en medicina regenerativa, para destapar toda la verdad detrás del boom viral de los péptidos para bajar de peso y la longevidad saludable.Finalmente, exploramos el futuro de la medicina de precisión, donde la inteligencia artificial promete diseñar péptidos a la medida exacta de cada paciente analizando cientos de biomarcadores como la insulina y la hemoglobina glicosilada.Shownotes00:00 | La verdad sobre los péptidos y la inteligencia artificial en medicina02:32 | Por qué se volvieron virales los péptidos para bajar de peso (El efecto Ozempic)04:16 | Qué es un péptido y cómo funciona la comunicación celular05:08 | Tipos de péptidos: Diferencias entre péptidos naturales y sintéticos06:51 | Por qué los péptidos no son suplementos alimenticios de venta libre17:33 | Cómo optimizar biomarcadores y salud con péptidos en la familia19:25 | Cómo mejorar la energía mitocondrial y el rendimiento sexual21:57 | La verdad sobre los péptidos metabólicos y la pérdida de grasa visceral25:05 | Los riesgos de perder masa muscular con péptidos para adelgazar27:36 | Qué hacer cuando usas péptidos: El plan obligatorio de ejercicio de fuerza29:42 | Cómo revertir la infertilidad y mejorar el microambiente celular32:41 | Por qué tienes la energía baja y cómo repararla desde la mitocondria40:39 | El protocolo médico de aplicación: Analíticas de sangre y resistencia a la insulina42:44 | Qué es la hemoglobina glicosilada y cómo mide la oxidación de tu cuerpo46:21 | Tipos de administración de péptidos: Vía subcutánea, oral, tópica y nasal49:55 | Cómo ciclar los péptidos de longevidad para evitar efectos secundarios52:51 | Los 5 errores y peligros graves de automedicarse con péptidos de internet55:16 | Por qué demandan a Ozempic: Casos de ceguera, tumores y cargas tóxicas59:36 | Cómo mitigar riesgos médicos empezando con dosis bajas1:02:58 | Cómo hacer un seguimiento con bioimpedancia, Dexa Scan y analíticas1:04:33 | Para qué sirve el BPC 157: El péptido para sanar lesiones, tendones e intestino1:10:30 | Contraindicaciones del BPC 157: Cuándo NO debes aplicártelo1:14:25 | Los beneficios del GHK-Cu (Tripéptido de Cobre) para la piel, cabello y células madre1:17:47 | La verdad sobre la Tesamorelina y la reducción de la grasa visceral1:22:09 | Qué es el Epitalón y cómo influye en los telómeros y la longevidad1:24:14 | Los mejores péptidos para el sueño profundo y la ansiedad (DSIP y Selank)1:29:28 | El futuro de la medicina de precisión: Péptidos personalizados con IA1:32:23 | Cómo llegar a los 120 años con vitalidad y envejecimiento saludable1:35:15 | El consejo final del Dr. Joaqui sobre el mercado negro de la saludSi te gustó este episodio, te recomendamos ver:- https://youtu.be/Bg0_zMYSdSM- https://youtu.be/MCkAu7OhAeY- https://youtu.be/1Lr90wz7fKY- Recibe 5% de descuento en tu suscripción de los mejores suplementos utilizando el código CREADORES en https://belevels.com/- Recibe acceso gratuito a mi lista de los 100 libros que transformarán tu vida aquí: https://www.creadores.co/newsletter- Únete a nuestra Escuela de Creadores, un programa de 12 semanas para transformar tu cuerpo, mente y negocios: https://creadores.co/escuela- Invierte en bienes raíces en EE. UU. con nosotros en Creadores Capital y genera retornos promedio del 20% anuales. Aplica aquí: https://www.creadorescapital.com/Redes de Dr. Joaqui:- https://www.instagram.com/dr.joaqui/- https://drjoaqui.com/- https://www.youtube.com/@cuerpomentemedicinafuncionaleiCreadores- Facebook: https://www.facebook.com/creadorespodcast- Instagram: https://www.instagram.com/creadorespodcast- Instagram: https://www.instagram.com/chelozegarra- TikTok: https://www.tiktok.com/@marcelozegarrac- Twitter: https://twitter.com/chelozegarrac- Email: https://www.creadores.co/contacto

¿Sabías que el secreto para frenar el envejecimiento no está en una crema, sino en tus riñones?

GLP-1 drugs were first approved to treat diabetes and then caused a frenzy when it was discovered they were great for weight loss. But now scientists are discovering the drugs that have brand names including Ozempic and Mounjaro might offer so much more, from reducing the risk of heart attack to treating kidney disease. Today, Doctor Paul Joyce, a pharmaceutical scientist at Adelaide University on how Ozempic is shaking things up, again. Featured:  Doctor Paul Joyce, a pharmaceutical scientist at Adelaide University 

Julia Cartwright examines what Ozempic actually is — a diabetes medication, not an FDA-approved weight-loss drug — and explores the real experiences behind the headlines. We discuss effectiveness ranges, common side effects like nausea and gastroparesis, weight regain after stopping, and why semaglutide works best as one tool in comprehensive care. Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI

Semaglutide. Tirzepatide. Retatrutide. The peptide conversation has taken over every gym, group chat, and social media feed. But the part about muscle loss, osteopenia, and what the gray market is actually selling you? That part is getting buried. Chalene Johnson sits down with Adam Schafer, co-host of Mind Pump, one of the top fitness podcasts in the world with nearly half a billion downloads. Adam spent three and a half years running real test groups on GLP-1s including Ozempic and Wegovy. What he found changed his perspective entirely and he is not holding back. This conversation covers what is actually driving muscle and bone density loss in women over 40 and 50, why the scale and the mirror are lying about body composition, and what most women are getting wrong about building real strength in midlife. Plus the truth about the gray market and what those peptides may actually contain. This is the conversation the fitness industry is not having and it is one every woman over 40 needs to hear.

In part two of the GLP-1 series, Melissa gets practical. What does it actually feel like to be on this medication? What does responsible use look like day to day? And how do you get the best results at the lowest effective dose possible?Whether you just started, you're a few months in, or you're wondering why you're not seeing the results you expected — this episode is for you.IN THIS EPISODE, YOU'LL LEARN:Why you forget about food on a GLP-1 and why that feeling of relief is also where your responsibility beginsWhat the flat affect actually is, why it happens, and what it tells you about your doseWhy GLP-1 receptors live in the brain's reward center — and what that means for your dopamine, your drive, and your nervous systemThe difference between microdosing and the lowest effective dose (and why that distinction matters more than the label)FDA-approved dosing for semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro) — and where Melissa would actually startWhy digestion has to come first before or while on this medicationThe truth about blood sugar stability on a GLP-1 and why the medication doesn't do that work for youWhy women on GLP-1 are losing muscle without realizing it — and exactly what to do about itProgressive overload: what it actually means and why going through the motions isn't enoughWhy Melissa recommends Cronometer over MyFitnessPal for tracking on a GLP-1Hair loss — medication side effect or weight loss side effect? Melissa breaks down the differenceFatigue — why it's actually both, and what to do depending on which one it isWhy perimenopause symptoms can get louder on a GLP-1 and what's happening hormonallyHow to know if you're actually at a plateau (hint: four weeks is the threshold)What to do when you're at max dose and the scale still isn't movingHow long is it okay to stay on a GLP-1 — and what the long-term concerns actually areTIMESTAMPS:00:00 — Welcome back + recap of episode one 01:45 — What it actually feels like when you first start 03:30 — The flat affect and the dopamine loop 07:50 — Strength training as a natural dopamine regulator 10:00 — The lowest effective dose and what microdosing actually means 12:00 — Semaglutide dosing overview (Wegovy, Ozempic) 13:45 — Tirzepatide dosing overview (Zepbound, Mounjaro) 15:00 — How to advocate for a lower starting dose with your provider 16:00 — Melissa's personal experience: 1 mg tirzepatide for inflammation 23:30 — Making the medication work hard for you: the foundation 25:00 — Digestion first — why gut health matters before you start 26:30 — Blood sugar stability is your responsibility 29:00 — Protein first, always 31:00 — Why women on GLP-1 are losing muscle 33:30 — Progressive overload — what it actually looks like 35:00 — Track your food — why Cronometer and why it's non-negotiable 38:30 — Side effects: medication vs. weight loss (two different categories) 39:00 — Hair loss explained 40:50 — Fatigue explained 42:00 — Nausea, constipation, gut symptoms 42:45 — Perimenopause, hormonal shifts, estrogen dominance44:30 — How to know if you're actually at a plateau 48:00 — Max dose: what to do when you're there 48:30 — How long is it okay to stay on a GLP-51:00 — Download the GLP-1 Support Guide + closeRESOURCES:Download the GLP-1 Support Guide — everything you need to use this medication responsibly: workouts with logging space, protein meal plan, nutrition framework, and tracking tools. melissaeichwellness.com/GLP1guideBook a free consultation with Melissa — whether you're considering GLP-1, already on it, or wanting gut or hormone support while on it: https://melissaeichcoaching.practicebetter.io/#/6490bd200e37c64b346b25c8/bookings?s=6a0cb936104f4243883a46dfGut Healing Program or Complete Hormone Program: https://melissaeichcoaching.practicebetter.io/#/6490bd200e37c64b346b25c8/bookings?s=69fe864f4b36932a1ec4aba4Related episodes:Episode [#179]: GLP-1 Series, Part 1 — The Shame, the Gray Area, and Weight Loss Resistance: https://podcasts.apple.com/us/podcast/179-glp-1-for-midlife-women-where-to-begin-part-1-3/id1650475536?i=1000771142749DUTCH test series — perimenopause, weight loss resistance, and estrogen detox - https://podcasts.apple.com/us/podcast/176-perimenopause-weight-gain-and-the-dutch-test/id1650475536?i=1000767363294CONNECT WITH MELISSA:Instagram: @melissa_eich Website: melissaeichwellness.com Email: melissa@melissaeichwellness.comABOUT THE SHOW:Body-Led by Design is a podcast for women who are done guessing and ready to understand what's actually happening in their bodies. Hosted by Melissa Eich, registered nurse, hormone and nervous system coach, and somatic practitioner, each episode brings the real conversations from her practice so you can walk away more informed, more empowered, and a little less alone in what you're navigating.LEAVE A REVIEW:If this episode resonated with you, a five-star review means the world. It helps more women find this podcast and get the information they actually need.SEO KEYWORDS:GLP-1 side effects, semaglutide weight loss, tirzepatide lowest effective dose, microdosing GLP-1, hair loss on Ozempic, muscle loss GLP-1, weight loss plateau GLP-1, GLP-1 fatigue, Wegovy responsible use, perimenopause GLP-1, how long to stay on GLP-1, GLP-1 support women over 40

Timestamps : 00:00 — Intro — Welcome to the Holistic Kids Show 00:20 —  The Childhood Obesity Crisis: The Numbers 01:14 — Guest Introduction: Ashley Koff, RD 02:12 — Ashley's Personal Story & What Drove Her Mission 04:34 — Rethinking Weight: It's a Signal, Not a Sentence 05:15 — Introducing Your Best Shot & Weight Health 06:07 — Understanding Hormones: GLP-1, GIP, CCK & PYY Explained Simply 08:15 — How Gut Hormones Control Blood Sugar, Appetite & Bone Health 10:16 — The Gut-Hormone Connection: Why Your Microbiome Matters 11:05 — Can Kids Take GLP-1 Hormones? 11:25 — Ozempic, Wegovy & GLP-1 Medications Explained 13:40 — GLP-1 Medications Approved for Kids 10+ — What Parents Must Know 15:28 — 3 Daily Habits to Naturally Balance Your Hormones 17:21 — Habit #2: Eat Like a Race Car — Fueling at the Right Times 18:04 — Habit #3: Move After Every Meal — Why 7 Minutes Matters 22:03 — "Better, Not Perfect" — What That Really Means for Teens 25:00 — The One Nutrition Rule Every Kid Should Know 29:49 — Where to Find Ashley Koff & Her Resources One in five US children lives with obesity — but are we asking the right questions? In this powerful episode, the Holistic Kids crew sits down with Ashley Koff, RD, USA Today bestselling author of Your Best Shot and a leading weight health practitioner with over 25 years of experience. Ashley flips the script on how we talk about weight with kids — moving away from diets, BMI, and body shame, and toward understanding what the body is actually telling us. She explains how hormones like GLP-1, GIP, and PYY are made in the gut lining, why antibiotics and medications can disrupt them for years, and what that means for growing bodies. The conversation also tackles the rising use of GLP-1 medications (like Ozempic and Wegovy) in kids as young as 10 — what the research says, what parents and teens should know, and why these medications are a tool, not a solution on their own. In this episode, you'll learn: Why weight is a signal, not a sentence What GLP-1, GIP, and gut hormones actually do — explained simply How antibiotics and medications affect your hormones for years The truth about GLP-1 medications for kids and teens 3 daily habits to naturally support hormone balance Why BMI is a flawed measure — and what to look at instead The "race car" nutrition approach that keeps your body running better What "better, not perfect" really means for teenagers Guest: Ashley Koff, RD — Founder of The Better Nutrition Program, author of Your Best Shot, recognized by CNN as one of the Top 100 Health Makers.

The American Radicals Podcast covers organic food, "Ozempic butt," unaffordable housing, out-of-control defense spending, and technology's impact on intelligence. Check us out on Spotify! https://open.spotify.com/show/09AZ2WuYnWbZ2941wsb6jW?si=76c005605dc64dc1 https://thehighwire.com/editorial/the-organic-label-is-a-promise-thousands-of-grocery-stores-were-breaking-it/ https://ers.usda.gov/topics/natural-resources-environment/organic-agriculture https://www.bbc.com/news/articles/c62r285l46eo https://archive.ph/LhoyW https://www.bankrate.com/mortgages/american-dream-of-homeownership-turning-into-luxury/ https://www.businessinsider.com/save-plan-student-loan-borrowers-most-expensive-repayment-trump-changes-2026-6 https://www.cbsnews.com/news/social-security-trust-fund-insolvency-2032-trustees-report/?ftag=CNM-00-10aab7e&linkId=958351867 https://www.ssa.gov/news/en/press/releases/2026-06-09.html https://dailycaller.com/2026/06/10/house-oversight-committee-shines-light-on-extensive-waste-in-us-military-spending/ https://www.gao.gov/assets/gao-26-109135.pdf https://thehighwire.com/editorial/the-30-billion-screen-experiment-that-failed-our-children/ https://www.the74million.org/article/long-term-naep-shows-growth-for-nine-year-olds-more-disappointment-for-teens/ https://archive.ph/0eMH4

Hey Diabuddy thank you for listening to show, send me some positive vibes with your favorite part of this episode.In this episode, Coach Ken sits down with Kelly Schmidt, diabetic dietitian and longtime Type 1 diabetes advocate, to have a deep conversation about one of the biggest topics in diabetes right now:With medications like Ozempic and other GLP-1-based therapies becoming more common, there are a lot of questions:1. Are these just weight-loss medications?2. Can people with Type 1 diabetes benefit from them?3. How do you use them safely?4. What happens with food, muscle, digestion, and long-term health?Kelly shares her personal experience using GLP-1 medications since 2017 and explains why these medications are about much more than weight loss. The conversation explores how GLP-1s impact appetite, digestion, hormones, inflammation, and blood sugar management.Ken and Kelly also discuss the difference between single agonists and dual agonists, why the “strongest” medication is not always the best medication, and why having conversations with your healthcare team is critical when deciding what works for your individual needs. The episode also dives into some of the biggest concerns people with Type 1 diabetes have:Can GLP-1 medications worsen gastroparesis?Do they cause bone loss?How do you protect muscle while using these medications?What role do protein and strength training play?Kelly shares practical guardrails around using these medications, including the importance of adequate nutrition, resistance training, and building systems that support your health—not just chasing a number on the scale.This episode is an honest conversation about a rapidly evolving area of diabetes care and how people with Type 1 diabetes can ask better questions, understand their options, and make informed decisions with their healthcare team.

If you suffer from "Ozempic Butt", there may be good news for you?

Join Udi Lazimy, Founder & CEO of FUDI Protein, for a conversation on what may be the most important protein opportunity hiding in plain sight — and why the food industry has been routing it through a cow instead of putting it on your plate.After leading Sourcing and Sustainability at Eat Just — makers of Just Mayo and Just Egg — Udi saw firsthand how fragile and opaque alternative protein supply chains had become. His answer was FUDI: a food and agtech startup built on regenerative American-grown alfalfa, near-field mobile processing, and a circular model that returns byproducts to farmers as premium feed. The result is RuBisCO — the most abundant protein on Earth — unlocked for human food for the first time at commercial scale.In this episode, we get into the science, the supply chain logic, the crowdfunding strategy, and what it really takes to build a protein company that can rival egg white and whey on performance, price, and sustainability.

We can enhance athletic performance, lose weight with a pill and even take psychedelics to alter consciousness. At what point does all this self-optimization become self-obsession? When does it get in the way of our humanity itself? My guest this week is the German biotech entrepreneur Christian Angermayer, who believes scientific breakthroughs to extend our lives — and even put us in touch with the divine — are close at hand. 0:00 - Intro 01:40 - Investing in longevity, A.I. and psychedelics 6:06 - The vision for the Enhanced Games 13:45 - Normalizing enhancements for everyone 20:02 - Ozempic is the first of many... 30:00 - The five basics for health and well-being 36:52 - Psychedelics trips and spiritual revelations 59:20 - Christian skepticism 01:04:22 - "Jesus is not human-maxxing." Thoughts? Email us at interestingtimes@nytimes.com.  Read the full transcript here: https://www.nytimes.com/2026/06/11/opinion/better-sex-better-hair-better-sleep-humanmaxxing-is-here.html Unlock full access to New York Times podcasts and explore everything from politics to pop culture. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Could eating late at night be hurting your gut health? Are prebiotic and probiotic sodas actually good for your microbiome? And what do GLP-1 weight loss drugs such as Ozempic and Wegovy mean for digestion, constipation, and gut bacteria? Dr. Will Bulsiewicz joins Chuck Carroll on The Exam Room Podcast to answer the most Googled gut health questions from listeners.

You get droopy.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Peptides are everywhere. Ozempic won't leave the headlines. And social media seems determined to convince us that the next health breakthrough is only one purchase away. So what's actually worth paying attention to? In this episode, Danielle welcomes celebrity trainer, nutrition scientist, and bestselling author Harley Pasternak for an unfiltered conversation about the biggest wellness trends dominating the internet right now. From peptides and Ozempic to detoxes, supplements, fiber-maxxing, and celebrity health culture, Harley breaks down what's backed by science, what's overhyped, and what's potentially dangerous. In this episode, you'll learn: Why Harley says most peptides being promoted online are essentially an uncontrolled experiment on human beings The surprising reason he trusts Ozempic and GLP-1s, but remains deeply skeptical of most other peptides The scary reality of what's actually being found inside many peptides sold online Why "Big Pharma doesn't want you to know" is often a red flag, not a revelation The wellness trend Harley says has absolutely no evidence behind it How social media created a generation of people taking supplements they can't explain Why Harley changed his mind about Ozempic after years of opposing it The concept of "food noise" and what GLP-1s may actually be doing inside the brain The shocking reason Harley walked away from The Biggest Loser before it became a hit Why focusing on weight loss can make you less healthy (and what to focus on instead) The Viktor Frankl quote that completely changed Harley's approach to health, happiness, and success The lesson about weight loss that most busy people miss Why intermittent fasting may be a lot less revolutionary than you've been led to believe The one form of exercise Harley believes every woman should prioritize—even if she hates it What working with Jessica Simpson, Megan Fox, Halle Berry, and the Kardashians taught Harley about discipline and success In a world obsessed with hacks, shortcuts, and miracle solutions, what Harley says actually works Make sure to follow Harley on Instagram @harleypasternak Check out Harley’s latest book The Carb Reset hereSee omnystudio.com/listener for privacy information.

Καλεσμένος ο Δρ. Αριστομένης Τουρβάς, Παθολόγος–Εντατικολόγος, με πιστοποίηση SCOPE και εξειδίκευση στην παχυσαρκία.   Μια νέα εποχή φαίνεται να ξεκινά στην αντιμετώπιση της παχυσαρκίας. Σε κλινικές μελέτες ενός νέου φαρμάκου, ασθενείς έχασαν πάνω από το 25% του βάρους τους. Μέσα σε λίγα χρόνια, φάρμακα όπως το Ozempic, το Wegovy και το Mounjaro πέρασαν από τα ιατρεία και τα επιστημονικά συνέδρια, στα πρωτοσέλιδα, στα social media και στις καθημερινές συζητήσεις. Για κάποιους αποτελούν μια επανάσταση στην ιατρική. Για άλλους, μια εξέλιξη που συνοδεύεται από μεγάλες προσδοκίες αλλά και σημαντικά ερωτήματα για την ασφάλεια, τη χρήση και το μέλλον τους.   Μπορούν πραγματικά αυτά τα φάρμακα να αλλάξουν τον τρόπο με τον οποίο αντιμετωπίζουμε την παχυσαρκία; Πόσο αποτελεσματικά και πόσο ασφαλή είναι; Σε ποιους απευθύνονται; Και βρισκόμαστε πράγματι μπροστά σε μια νέα εποχή στην ιατρική; Ίσως στη σημαντικότερη εξέλιξη στην αντιμετώπιση της παχυσαρκίας από τότε που η ιατρική άρχισε να τη θεωρεί νόσο;

This week's episode of Punk Rock Sober is brought to you by Betterhelp. Sign up and get 10% off at https://www.betterhelp... - Life is a journey, don't go through it alone. We're also brought to you by OneSkin. Get 15% off OneSkin with the code Punk Rock at https://www.oneskin.co #oneskinpod Are peptides the future of recovery, longevity, and health optimization? In this episode of Punk Rock Sober, Tyler Ramsey sits down with Nurse Mel Mansell, functional medicine expert, registered nurse, and co-host of the What Do You Want?! podcast. Together they dive deep into the exploding world of peptides, GLP-1 medications, Ozempic, semaglutide, NAD therapy, testosterone replacement, anti-aging treatments, addiction recovery, and the science behind longevity. Nurse Mel shares real-world stories from patients who have used GLP-1 medications to overcome alcohol addiction, lose significant weight, and improve their health. She also explains the risks of black-market peptides, discusses the hype surrounding "wonder drugs," and reveals why foundational habits like sleep, exercise, nutrition, and stress management still matter most. If you're curious about Ozempic, peptides, recovery, biohacking, longevity, or the future of health optimization, this conversation is packed with practical insights and surprising truths. #PunkRockSober #Ozempic #Peptides #GLP1 #RecoveryPodcast #AddictionRecovery #Longevity #Biohacking #NAD #Semaglutide

The Gary & Shannon Show Hour 2 (06.10) – Gary and Shannon discuss the growing influence of Democratic Socialists in Los Angeles and why Nithya Raman's surge may say more about the city's political future than Spencer Pratt's headline-grabbing campaign ever did.They examine how social media can distort reality, why viral popularity doesn't always translate into votes, and how algorithms can make fringe movements appear larger than they are.Plus, the Talkback Prediction Game returns with an unexpected compliment for Shannon and an unfortunate outcome for Gary, restaurants prepare for a World Cup tourism boom with automatic gratuities, and Shannon's comments about Henri DiCarlo's hair somehow make their way back to Henri himself.Finally, they explore the latest wellness trend nobody asked for: Ozempic ears.See omnystudio.com/listener for privacy information.

GLP-1 medications like Ozempic, Wegovy, and Zepbound have become some of the most talked-about treatments for weight loss, but their benefits may extend far beyond the scale. In this episode, Diana breaks down what GLP-1 medications are, how they work in the body, and what current research shows about kidney health. She explores the growing evidence for kidney protection, discusses emerging research in autosomal dominant polycystic kidney disease (ADPKD), and shares practical considerations for people with PKD who are considering semaglutide or tirzepatide medications. SHOW NOTES, REFERENCES, & TRANSCRIPTS www.thepkddietitian.com/58 Episode #57: Weight Loss & PKD: Can It Slow Kidney Growth and Disease Progression? GLP1 Clinical Trial: Glucagon-Like Peptide-1 Receptor Agonist in ADPKD FLOW Trial: https://pubmed.ncbi.nlm.nih.gov/38785209/ Support the Show: patreon.com/PKDDietitian WORK WITH DIANA: thepkddietitian.com/workwithme HAVE A QUESTION? Send a message to info@thepkddietitian.com FIND THE PKD DIETITIAN ONLINE Patreon: PKDDietitian Instagram: @The.PKD.Dietitian Facebook: The PKD Dietitian Website: thepkddietitian.com Support the show and access future bonus content and deeper PKD nutrition insights: patereon.com/PKDDietitian DISCLAIMER The PKD Dietitian Podcast is for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.

I have a weird sense of humor, and I'm strangely proud of my butt...In today's episode, Monica makes candy for her neighbors, Rachel and Tag are a little too obvious at the office, and Ross teaches Phoebe how to ride a bike...Plus, Katie and Chloe talk about Obsession, Ozempic, and backyard nudity. WARNING: Discussion of eating disorders and dieting from 6:00 to 24:00. FOLLOW US ON SOCIAL MEDIA:Katie - @lilbabykatesChloe - @cuckooforchlochlopuffsPodcast - @theywereonabreakpod

Morse code transcription: vvv vvv Sikh group calls for public inquiry into Henry Nowaks death New drug to stop Ozempic butt muscle loss side effect of obesity jabs Who is David Sullivan football boss, king of porn and alleged sexual predator Billionaire West Ham co owner David Sullivan accused of preying on women for sex Drug gangs cuckooing hundreds of homes a week, police tell BBC Lives still at risk from unregulated baby sleep industry after BBC investigation Driving test booking rules tightened after thousands of no shows Top five a day foods new study says your heart needs Kemi Badenoch to call for scrapping of legal equality duty World Cup 2026 Somali referee Omar Artan to miss tournament after being barred from entering US

Your body already makes peptides every single day — so before you write them off as another wellness trend or jump on the Ozempic hype train, it's time to actually understand what they are. In this episode of The Wellness Effect, we breaks down peptides from the ground up — no hype, no fear, just a real explanation of what they are, how they communicate with your body, and why the conversation is so much bigger than weight loss. She walks through five specific peptides (semaglutide/Ozempic, retatrutide, BPC-157, GHK-Cu, and CJC-1295/ipamorelin), explains where they sit on the spectrum between supplements and steroids, and makes the case for why foundations always come first — even if you're curious about peptides for gut healing, skin, recovery, or longevity.   KEY TAKEAWAYS: 1. Peptides aren't supplements and they aren't steroids — they're precision keys that fit one specific lock and turn on one specific system. More targeted than a supplement, way less system-wide than a steroid. 2. "Peptides" ≠ "Ozempic." The peptide world covers gut healing, skin, recovery, longevity, and more. The weight-loss lens is exactly why everyone's either over-hyped or scared. 3. Foundations first — always. Sleep, food, movement, stress. No peptide, no matter how well-targeted, will land in a body running on empty.   Chapters: (00:00) Welcome (00:51) What Even Is a Peptide? The Lego Brick Breakdown (05:45) Peptides as Messengers: The Lock and Key System (06:50) How Peptides Differ from Hormones (10:54) Peptide Levels Decline with Age (and Why That Matters) (12:44) The Spectrum: Supplements → Peptides → Steroids (19:24) Peptides vs. Endocrine Disruptors — Are They the Same? (25:20) Why Is Everyone Suddenly Talking About Peptides? (31:10) Peptide #1: Semaglutide (Ozempic/Wegovy) (39:45) Peptide #2: Retatrutide — The Next Generation GLP-1 (42:52) Peptide #3: BPC-157 — Gut Healing & Injury Recovery (47:17) Peptide #4: GHK-Cu — The Skin, Collagen & Longevity Peptide (53:47) Peptide #5: CJC-1295 + Ipamorelin — Growth Hormone & Recovery (01:01:00) Why Foundations Always Come First (01:09:57) The Wrap-Up: What to Actually Take Away From This   Want to Work With Us? Join us in the Root Cause Reset Program: https://www.lifestyleucoaching.ca/wellness-effect-906145 and use code "Wellness Effect" for a FREE functional lab test when you join the program. Follow us on Instagram: The Podcast: https://www.instagram.com/thewellnesseffectpod/ Lacey Iskra - https://www.instagram.com/laceeiskk/ Jensen - https://www.instagram.com/wellnesswjensen/ Kira Iskra - https://www.instagram.com/wellbykira/ Lifestyle U have helped over 1,000+ women transform their mind and body and become the best version of themselves. Want to be next? Click Here to Apply! - https://www.lifestyleucoaching.ca/apply If you loved this episode and want to hear more, subscribe and leave a review! Share this episode with a friend who's ready to start their own wellness journey. Follow us on Instagram at https://www.instagram.com/thewellnesseffectpod/ to stay up-to-date with the latest episodes and tips.  

What is one of the newly found side effects of taking Ozempic?

Morse code transcription: vvv vvv Who is David Sullivan football boss, king of porn and alleged sexual predator World Cup 2026 Somali referee Omar Artan to miss tournament after being barred from entering US Kemi Badenoch to call for scrapping of legal equality duty Billionaire West Ham co owner David Sullivan accused of preying on women for sex Drug gangs cuckooing hundreds of homes a week, police tell BBC Sikh group calls for public inquiry into Henry Nowaks death Lives still at risk from unregulated baby sleep industry after BBC investigation Top five a day foods new study says your heart needs Driving test booking rules tightened after thousands of no shows New drug to stop Ozempic butt muscle loss side effect of obesity jabs

Morse code transcription: vvv vvv Who is David Sullivan football boss, king of porn and alleged sexual predator Billionaire West Ham co owner David Sullivan accused of preying on women for sex Kemi Badenoch to call for scrapping of legal equality duty World Cup 2026 Somali referee Omar Artan to miss tournament after being barred from entering US Lives still at risk from unregulated baby sleep industry after BBC investigation New drug to stop Ozempic butt muscle loss side effect of obesity jabs Driving test booking rules tightened after thousands of no shows Sikh group calls for public inquiry into Henry Nowaks death Drug gangs cuckooing hundreds of homes a week, police tell BBC Top five a day foods new study says your heart needs

Tim Conway Jr Show Hour 3 (6.8) Conway kicks off the hour with the latest on Primm casino resorts, as LV Petroleum emerges as a leading potential buyer and operator trying to save the properties before a possible July 4 shutdown. The desert drama continues as the Primm family looks for a new partner to keep the casino town alive. Then the news turns global and wild: a plane headed to pick up MLB legend Yadier Molina and his family crashes on its way to Texas, a massive 7.8 earthquake strikes the southern Philippines, and a rare 6.1 earthquake rattles off the coast of Cuba. The crew jumps into NBA Finals fever with Knicks vs. Spurs, Game 3, and the insane ticket prices surrounding New York’s run — from thousands just to get in the building to courtside seats going for hundreds of thousands. Later, Conway gets into new weight-loss drugs, changing body sizes, and how GLP-1s are creating chaos for retail returns as people keep swapping clothes while trying to find their new size. Plus, Bellio’s yacht wedding, Conway trying to escape a cruise, strange things spotted on walks, and one beard that was apparently a total turnoff. The hour wraps with the sad wave of Southern California restaurant closures, including memories of Gulliver’s in Newport Beach, as rising food costs, labor costs, regulations, and changing spending habits put pressure on longtime local favorites. Primm casinos, LV Petroleum, Yadier Molina, Philippines earthquake, Cuba earthquake, Knicks vs Spurs, NBA Finals, Knicks tickets, weight loss drugs, GLP-1, Ozempic, retail returns, yacht wedding, restaurant closures, Gulliver’s Newport Beach, Southern California, Conway Show See omnystudio.com/listener for privacy information.

Linktree for Community ResourcesNeed help appealing a GLP-1 Insurance Denial? FindHonestCare.com/KimRo - Telehealth for GLP1 Weight ManagementThe Absolute Lies You've Heard About GLP-1s (Ozempic Myths Debunked) [REPLAY]Are you being lied to about Ozempic, Mounjaro, and Wegovy? In this special replay episode, leading obesity medicine specialists break down the biggest GLP-1 myths taking over your feed. We are reposting this crucial conversation because it is more relevant than ever. With GLP-1 price changes and expanding access options through federal programs like the Medicare GLP-1 Bridge, understanding the real science behind these medications is essential for patient advocacy.We are sharing a few favorite replay episodes right now while Kim is away on bereavement leave following the loss of her sister. We want to deeply thank our subscribers for staying engaged and supporting the show during this time.In this episode of The Plus Sidez Podcast, Kat joins Kim to sit down with obesity medicine specialists Dr. Matea Rentea and Dr. Ali Novitzki to help listeners better understand their disease and feel empowered in their healthcare journey.The Myths We Debunk:The Muscle Loss Scare: The data behind weight loss and body composition, explaining why the medication itself is not destroying your lean mass.The Willpower Narrative: Why obesity is a genetic, chronic metabolic disease rooted in brain biology, not a failure of personal willpower.The Shot-Only Illusion: How the medication works alongside your body's natural satiety signals and gut receptors.Obesity Doctor Guidance Shared:Metabolic Protection: A practical discussion on utilizing a 10-minute fitness routine and a 100-gram protein framework to maintain lean mass and support insulin sensitivity.System Navigation: Insights on navigating insurance barriers, managing prior authorizations, and advocating for proper medical care.Mental Resilience: Tools to process unsolicited comments about your weight and protect your peace from societal judgment.Episode Topics:Why We Are Replaying This Episode: Prices, Access, and UpdatesThe Insurance Landscape: Understanding Prior AuthorizationsMeet the Obesity Medicine SpecialistsDeconstructing the GLP-1 Muscle Loss NarrativeStrategies for Protecting Your MetabolismWhat the Scales Do Not Show About Insulin ResistanceNatural Satiety Triggers and Gut ReceptorsRecognizing Obesity as a Biological Chronic DiseaseAddressing Weight Stigma and External CommentarySubscribe to The Plus Sidez Podcast for science-backed episodes breaking down metabolic health, body recomposition, and the truth about weight loss.Search TagsGLP1 lies debunked, Ozempic myths, Mounjaro weight loss journey, Wegovy truth, Zepbound body recomposition, insulin sensitivity hacks, natural GLP1 boosters, treating obesity metabolic disease, plus sidez podcast, dr matea rentea, dr ali novitzki_________________________________________________________________________Join this channel to get access to perks:https://www.youtube.com/channel/UC0HUIGKl3BN4Vg6LYI-dkOA/join_________________________________________________________________________#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide  #GLP1 #Obesity #zepbound #wegovySend us Fan Mail!Support the showKim Carlos, Executive Producer TikTokInstagram Kat Carter,  Producer TikTokInstagram 

Click here for a Free Trial to my Full Body Workout Plan and here for my favorite post workout protein.

SLC is officially one of America's "stickiest" downtowns — we break down the new Gensler study and what it means (plus where Denver landed). The flesh-eating screwworm just crossed into Texas for the first time in 60 years. Utah officials are watching closely. The Utah prison system is saving taxpayer dollars with a complete healthcare redesign — but it raises some interesting questions. We dive in with the Morality Police. In Health Class, a new study says Ozempic and Wegovy may slow biological aging by 9%.  Ethan and Alex put their friendship to the test after reading about the red flags that suggest a friendship isn't worth saving. Plus: a 17-year-old drowns at Bear Lake and trauma season is here. Why do Americans hate sharing bathrooms? Scammers are using AI images of a missing Utah cat to demand thousands, a couple is charged for hoarding hundreds of "street rats," and a man lost $30K because squirrels love plant-based car parts. Plus, Uber drops its wildest lost-and-found list ever (dentures, a Donny Osmond photo, 420 donuts).  AI Question of the Day: What's the best way to handle pet deaths with kids?   Stream KSL NewsRadio LIVE: kslnewsradio.com/listen Watch on YouTube: https://www.youtube.com/@KSLBrightside Facebook: https://www.facebook.com/KSLBrightside Instagram: https://www.instagram.com/KSL_Brightside TikTok: https://www.tiktok.com/@ksl.brightside

Ever wish you could just eat a damn meal without overthinking it? Like actually feel full, satisfied, and not obsessed with whether you “earned it” or if it fits your macros?If calorie counting, macro tracking, and endless diets left you feeling stuck, stressed, and totally exhausted, this episode is your permission slip to do it differently.Today, I'm sitting down with Kylie, a real-life graduate of Mindful Weight Loss Academy, to get SUPER real about what it's like to go from hitting rock bottom (hi, crying over jeans that don't fit) to losing 28 pounds without restriction.We talk about ditching migraines, getting her cycle back on track, feeling genuinely good in her scrubs again, and—yep—actually enjoying food.This isn't just another “before and after” story. This is about reclaiming your life, your energy, and your peace of mind. If you've been lurking in the background, thinking “could this actually work for me?” Kylie's story is your sign.Whether you're scared to let go of control or just sick of starting over every Monday, this episode will show you that real change is possible…and sustainable.xoxo,JackieP.S. Want to see Kylie's before & afters? Check out our Instagram highlights and celebrate her journey!MORE FROM JACKIE: >

Peptides have gained a broad following across the country, promoted by everyone from online influencers to the nation's top health official, Robert F. Kennedy Jr. Now, there's a weight loss drug in development that's being touted as "Ozempic on steroids," but it has not been approved by the FDA. As our Adam Yamaguchi found, that hasn't stopped doctors from offering it for sale.LinkedIn's latest workforce report found hiring rates are nearly 5% lower than a year ago. Catherine Fisher, a LinkedIn career expert, explains how job applicants can break through the market, using AI when applying and more.Oscar-winning director Steven Spielberg talks to CBS News about his 34th feature film, "Disclosure Day," which explores what would happen if all of the evidence about UFOs and alien life was released to the entire world and proved we are not alone. He also discusses his opinion on aliens, saying they "have been here and they are here." CBS News contributor David Begnaud went to New Orleans to ask everyday Americans who believed in them. He spoke with 23-year-old Chris Wurl who described how a former coach made a major impact on his life.

One of the biggest questions people ask about GLP-1 medications is:“What happens if I stop taking it?”Whether you're taking Ozempic, Wegovy, Mounjaro, or Zepbound, you may have concerns about losing insurance coverage, reaching your goal weight, medication costs, long-term use, or the possibility of regaining weight in the future.In this episode, Registered Dietitian and GLP-1 expert Gianna breaks down what the research actually shows about stopping a GLP-1 medication, the factors that influence weight regain, and what you can start doing now to support long-term success.We're covering:What happens when you stop a GLP-1 medicationWhether weight regain is inevitableWhy hunger and food noise may change after discontinuationCommon myths about stopping Ozempic, Wegovy, Mounjaro, and ZepboundWhy willpower is not the solutionThe habits that support long-term weight maintenanceWhat to do if you lose access to your medicationHow to think about weight regain without shame or fearIf you've ever worried about what happens after a GLP-1, this episode will help you approach the conversation with more knowledge, less fear, and a realistic plan for the future.

A headline like “weight loss drugs may reduce breast cancer risk” grabs attention fast, but the real story lives in the fine print. We take you through a new Penn Medicine study that observed lower breast cancer rates among women with overweight or obesity who used GLP-1 medications, then we translate what that finding actually means in plain language. Observational data can reveal a signal worth studying, but it cannot prove the medication caused the outcome, and that distinction matters for your decisions and your expectations. We also zoom out to the bigger why: obesity is not just about body size. Fat tissue is biologically active, shaping chronic inflammation, estrogen exposure after menopause, insulin resistance, and even how well the immune system spots abnormal cells. Those pathways help explain why obesity is linked to many cancers, including postmenopausal breast cancer, and why researchers are curious whether effective obesity treatment could shift risk over time. Then we get practical. We review what stronger evidence from randomized controlled trials says so far: GLP-1 drugs like Ozempic, Wegovy, Mounjaro, and Zepbound do not appear to increase breast cancer risk in the available trial data, even though most trials were not designed to study cancer outcomes for many years. We also discuss why newer studies seem most suggestive for hormone receptor positive breast cancer, along with the leading theories: weight loss itself, improved metabolic health and insulin signaling, reduced inflammation, and the still-unclear possibility of direct GLP-1 effects in cancer biology. If you like evidence-based medicine with real-world context (and a little Philly-life banter), subscribe, share this episode with a friend, and leave a review so more people can find the show. What question do you want answered next about GLP-1s, obesity treatment, or cancer risk?ReferencesRisk for Cancer With Glucagon-Like Peptide-1 Receptor Agonists and Dual Agonists : A Systematic Review and Meta-Analysis. Ko A, Chang YC, Bahar F, et al. Annals of Internal Medicine. 2025;. doi:10.7326/ANNALS-25-02237.Do GLP-1 Receptor Agonists Increase the Risk of Breast Cancer? A Systematic Review and Meta-Analysis. Piccoli GF, Mesquita LA, Stein C, et al. The Journal of Clinical Endocrinology and Metabolism. 2021;106(3):912-921. doi:10.1210/clinem/dgaa891.Glucagon-Like Peptide 1 Receptor Agonists and Cancer Risk: The Good, the Bad and the Unknown. Mannucci E, Dicembrini I. Nature Reviews. Clinical Oncology. 2026;23(6):459-470. doi:10.1038/s41571-026-01135-0.GLP-1 Agonists Are Associated With a Significant Reduction in Breast Cancer Incidence in Women. McDonald ES, Gillis LB, Gabriel P, et al. JCO Oncology Practice. 2026;:101200OP2600485. doi:10.1200/OP-26-00485.GLP-1 therapy and hormone receptor–positive breast cancer risk and survival: A real-world analysis.. Shah Z, Hundal J, Afridi S, et al. Journal of Clinical Oncology. 2026;44(Suppl 16):10548. doi:10.1200/JCO.2026.44.16_suppl.10548.Survival and Recurrence With GLP-1 Receptor Agonists in Breast Cancer. Tatum KL, Dahman B, Stevenson A, et al. JAMA Network Open. 2026;9(5):e2612133. doi:10.1001/jamanetworkopen.2026.12133.Association of Glucagon-Like Peptide-1 Receptor Agonists With Risk of Cancers-Evidence From a Drug Target Mendelian Randomization and Clinical Trials. Sun Y, Liu Y, Dian Y, et al. International Journal of Surgery (London, England). 2024;110(8):4688-4694. doi:10.1097/JS9.0000000000001514.GLP-1 receptor agonists and breast cancer risk in type 2 diabetes.. Guo Cheng and Amanda Ward. Journal of Clinical Oncology. 2025;43(Suppl 16):10557. doi:10.1200/JCO.2025.43.16_suppl.10557.Glucagon-Like Peptide-1 Analogues and Risk of Breast Cancer in Women With Type 2 Diabetes: Population Based Cohort Study Using the UK Clinical Practice Research Datalink. Hicks BM, Yin H, Yu OH, et al. BMJ (Clinical Research Ed.). 2016;355:i5340. doi:10.1136/bmj.i5340.GLP-1 Receptor Agonists and Cancer: Current Clinical Evidence and Translational Opportunities for Preclinical Research. Valencia-Rincón E, Rai R, Chandra V, Wellberg EA. The Journal of Clinical Investigation. 2025;135(21):e194743. doi:10.1172/JCI194743.Send us a (voice ) message with this link, we would love to hear from you. Standard message rates may apply.Support the showProduction and Content: Edward Delesky, MD, DABOM & Nicole Aruffo, RNArtwork Rebrand and Avatars:Vantage Design Works (Vanessa Jones) Website: https://www.vantagedesignworks.com/Instagram: https://www.instagram.com/vantagedesignworks?igsh=aHRuOW93dmxuOG9m&utm_source=qrOriginal Artwork Concept: Olivia Pawlowski

What happens to bariatric surgery when GLP-1 medications like Ozempic, Wegovy, and Zepbound change the entire weight loss landscape?In this episode, Dr. Matthew Weiner and registered dietitian Zoe unpack what they saw at the 2026 ASMBS annual conference - a meeting that felt very different from prior years. Surgical volumes are down, many bariatric surgeons are wrestling with what GLP-1s mean for their practices, and patients are left trying to figure out whether medication, nutrition, surgery, or some combination makes the most sense.Dr. Weiner explains why bariatric surgery still matters, but no longer belongs in the same place in the treatment sequence. For many patients, a GLP-1 trial should come first. For others, especially non-responders, patients with severe diabetes, or people losing mobility, surgery may be the safest and most effective next step.They also discuss why low-dose GLP-1s may be more sustainable than high-dose treatment, how to recognize a medication non-response, and why the best obesity care in 2026 combines nutrition, medication, surgery, and long-term support instead of forcing patients into one silo.

Dans cet épisode, je reçois le Docteur Laurent Chevallier, médecin nutritionniste et auteur de Maigrir avec les nouveaux médicaments : révolution ou poison ?, pour parler d'un sujet qui déchaîne les débats depuis quelques années : les médicaments anti-obésité : les fameux GLP-1, Ozempic, Mounjaro. On les entend partout, on voit des stars en faire la promo, et pourtant on comprend rarement ce qu'ils font vraiment dans le corps, à qui ils s'adressent, et ce qu'ils ne règlent pas.Ce qui m'a frappée dans cet échange, c'est à quel point la question du poids est biologiquement complexe, bien au-delà du "mange moins, bouge plus" qu'on entend encore trop souvent.Dans cet épisode, on parle de :Pourquoi il est si difficile de maigrir, et ce que la science dit aujourd'hui sur la mémoire métaboliqueCe que sont vraiment les analogues GLP-1 : leur mécanisme d'action, leur histoire, et pourquoi ils ont d'abord été développés pour le diabèteLes trois effets concrets de ces médicaments : glycémie, estomac, cerveauCe qu'on perd vraiment quand on perd du poids rapidement : muscles, os, micronutrimentsLes carences silencieuses auxquelles faire attention et pourquoi les autres médicaments qu'on prend peuvent aussi être perturbésLes effets secondaires mineurs et les risques plus sérieuxPourquoi les critères actuels de prescription (IMC, poids) sont insuffisants et ce qu'il faudrait regarder à la placeCe qui se passe quand on arrête : les chiffres sur la reprise de poidsLa question des nouvelles formes orales à venir, et pourquoi le Dr Chevallier reste prudentLe rôle des perturbateurs endocriniens, des aliments ultratransformés et du stress dans l'obésitéCe que le Dr Chevallier prescrit vraiment et dans quelles situations précisesPourquoi il défend une médecine de prévention plutôt qu'une médecine de rattrapageEt vous : est-ce que cet épisode change votre regard sur ces médicaments ou sur la question du poids en général ? Dites-le moi en commentaire.Merci à WOJO, notre partenaire qui nous soutient en nous accueillant dans ses magnifiques locaux parisiens de Saint-Lazare !

Are ZYNs gas-station Ozempic or a dopamine loan shark? Nick Pell digs into the nicotine pouch boom this Skeptical Sunday — and the verdict is messy.Welcome to Skeptical Sunday, a special edition of The Jordan Harbinger Show where Jordan and a guest break down a topic that you may have never thought about, open things up, and debunk common misconceptions. This time around, we're joined by writer and researcher Nick Pell!Full show notes and resources can be found here: jordanharbinger.com/1340On This Week's Skeptical Sunday:ZYNs are a tobacco-free nicotine pouch born from Swedish "snus." Swedish Match engineers extracted nicotine salts and loaded them into food-grade fillers, creating a shelf-stable white pouch that doesn't stain teeth or require spitting. Philip Morris bought the company for $16 billion in 2022.The harm-reduction case is strong, but "less harmful" isn't "harmless." ZYNs skip the carbon monoxide, tar, and lung damage of cigarettes, and carry roughly 90 — 99% lower carcinogens. But they still raise heart rate and blood pressure, can cause gum recession, disrupt sleep, and remain wildly addictive.The user base skews young, male, and white. Men are 88% of the market, and the 19-30 bracket is fastest-growing, with use doubling in 2024-2025. Adoption is concentrated in white, high-income, urban circles like tech, law, and finance where smoking is socially radioactive.Nicotine has real cognitive perks — with a catch. A meta-analysis of 41 studies found genuine gains in alertness, reaction time, and focus, plus appetite suppression ("gas station Ozempic"). The catch: for addicts, these benefits mostly just return you to baseline rather than lifting you above it.If you already smoke, switching is a genuine win you can act on today. For a smoker, trading cigarettes for pouches is described as "trading a motorcycle for a minivan" — vastly less likely to kill you. Harm reduction beats abstinence-only, since switchers are twice as likely to stay off cigarettes as those using gum or lozenges.Connect with Jordan on Twitter, Instagram, and YouTube. If you have something you'd like us to tackle here on Skeptical Sunday, drop Jordan a line at jordan@jordanharbinger.com and let him know!And if you're still game to support us, please leave a review here — even one sentence helps! Sign up for Six-Minute Networking — our free networking and relationship development mini course — at jordanharbinger.com/course!Subscribe to our once-a-week Wee Bit Wiser newsletter today and start filling your Wednesdays with wisdom!Do you even Reddit, bro? Join us at r/JordanHarbinger!This Episode Is Brought To You By Our Fine Sponsors:SimpliSafe Home Security: 50% off + 1st month free: simplisafe.com/jordanProgressive Insurance: Free online quote: progressive.comProfile Guru: 50% off through June: MyProfileGuru.com, code JordanJune50AT&T: Get an iPhone 17 Pro for $0: att.com/iphone or visit an AT&T store for detailsSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

The Department of Justice abandoned its plan for a $1.8 billion “anti-weaponization” fund. The Wall Street Journal reports the fund had threatened to sink Trump’s broader immigration priorities. President Trump appointed Bill Pulte as acting director of national intelligence. Reuters’s Jonathan Landay joins to explain why he’s a controversial pick. The NBA Finals begin tonight. Tim Reynolds of the Associated Press breaks down the matchup between the New York Knicks and the San Antonio Spurs. Plus, why the Pentagon hired a Jan. 6 rioter for sensitive counterterrorism work, Secretary of State Marco Rubio publicly testified in Congress, and how Ozempic may be reshaping some people’s brains. Today’s episode was hosted by Gideon Resnick.